FSCDR’s Experience With Voxelotor (Gbt440) Treatment in Patients With Severe Sickle Cell Disease
ATLANTA — Lanetta Bronté, M.D., M.P.H., M.S.P.H., founder and chief health officer of the Foundation for Sickle Cell Disease Research (FSCDR) in Hollywood, Fla., presented results from seven adult sickle cell disease patients with severe anemia and...
Aug 28th, 2019